Executive Vice President
Fred Hutch Cancer Center
Seattke, Washington, United States
Dr. Fred Appelbaum helped develop Fred Hutch’s renowned program in blood stem cell transplantation and was the lead author of the first paper to describe the successful use of autologous bone marrow transplantation, a therapy now used in more than 30,000 patients annually. Beyond his own research, Dr. Appelbaum has been a national leader in the conduct of clinical trials. In his current leadership role at the Hutch, Dr. Appelbaum sets the vision and standards for clinical research across the Fred Hutch/University of Washington/Seattle Children's Cancer Consortium and oversees faculty affairs.
Disclosure information not submitted.
SOTA: Don Thomas and the History of Marrow Transplantation
Wednesday, June 18, 2025
9:30 AM – 10:30 AM ET
SOTA: Where Marrow Transplantation Will Take Us in the Future
Wednesday, June 18, 2025
10:45 AM – 11:45 AM ET